Discussion: Immunological therapeutics in ovarian cancer

被引：4
作者：
Balkwill, F [1 ]
Schlom, J
Berek, J
Epenetos, A
Bookman, M
Freedman, R
Wilbanks, G
机构：
[1] Imperial Canc Res Fund, Translat Oncol Lab, John Vane Sci Ctr, London, England
[2] London Queen Marys Med Sch, London, England
[3] NCI, Bethesda, MD 20892 USA
[4] Univ Calif Los Angeles, Los Angeles, CA 90024 USA
[5] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[6] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Univ S Florida, Tampa, FL 33620 USA
来源：
GYNECOLOGIC ONCOLOGY | 2003年 / 88卷 / 01期
关键词：
D O I：
10.1006/gyno.2002.6696
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S110 / S113
页数：4
相关论文
共 50 条
  • [21] BIOLOGIC AND IMMUNOLOGICAL THERAPY OF OVARIAN-CANCER
    BOOKMAN, MA
    BEREK, JS
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (04) : 941 - 965
  • [22] Immunonutrition in ovarian cancer: clinical and immunological impact?
    Ferrero, Annamaria
    Vassallo, Daniela
    Geuna, Massimo
    Fuso, Luca
    Villa, Michela
    Badellino, Enrico
    Barboni, Martina
    Coata, Paola
    Santoro, Nathalie
    Delgado Bolton, Roberto C.
    Biglia, Nicoletta
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 33 (06)
  • [23] Immunological aspects of ovarian cancer: Therapeutic perspectives
    Nayama, M.
    Collinet, P.
    Salzet, M.
    Vinatier, D.
    JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2016, 45 (09): : 1020 - 1036
  • [24] Specific keynote: Immunological therapy for ovarian cancer
    Berek, JS
    Dorigo, O
    Schultes, B
    Nicodemus, C
    GYNECOLOGIC ONCOLOGY, 2003, 88 (01) : S105 - S109
  • [25] Node clearance in ovarian cancer DISCUSSION
    Crepin, Gilles
    Binet, Jacques-Louis
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2010, 194 (01): : 49 - 50
  • [26] Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics
    Modesitt, Susan C.
    Jazaeri, Amir A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (14) : 2293 - 2305
  • [27] An Immunophenotyping of Ovarian Cancer With Clinical and Immunological Significance
    Yang, Kai
    Zhao, Weiwei
    Lou, Ge
    Rong, Zhiwei
    Xu, Huan
    Wang, Wenjie
    Song, Wei
    Cai, Yuqing
    Hou, Yan
    Li, Kang
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [28] Immunological and innovative forms of therapy in ovarian cancer
    Schnurch, HG
    GYNAKOLOGE, 1997, 30 (02): : 141 - 150
  • [29] Malignant Ascites in Ovarian Cancer and the Role of Targeted Therapeutics
    Smolle, Elisabeth
    Taucher, Valentin
    Haybaeck, Johannes
    ANTICANCER RESEARCH, 2014, 34 (04) : 1553 - 1561
  • [30] Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
    McCloskey, Curtis W.
    Rodriguez, Galaxia M.
    Galpin, Kristianne J. C.
    Vanderhyden, Barbara C.
    CANCERS, 2018, 10 (08)
12345